Dumont & Blake Investment Advisors LLC increased its holdings in Cigna Group (NYSE:CI - Free Report) by 21.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,068 shares of the health services provider's stock after acquiring an additional 1,054 shares during the quarter. Dumont & Blake Investment Advisors LLC's holdings in Cigna Group were worth $2,006,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Family Legacy Inc. lifted its stake in Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider's stock worth $2,138,000 after acquiring an additional 31 shares during the period. Impact Investors Inc lifted its stake in Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider's stock worth $650,000 after acquiring an additional 31 shares during the period. Westend Capital Management LLC lifted its stake in Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider's stock worth $140,000 after acquiring an additional 32 shares during the period. Financial Network Wealth Advisors LLC lifted its stake in Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider's stock worth $53,000 after acquiring an additional 34 shares during the period. Finally, Central Pacific Bank Trust Division lifted its stake in Cigna Group by 1.0% in the second quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider's stock worth $1,137,000 after acquiring an additional 35 shares during the period. Hedge funds and other institutional investors own 86.99% of the company's stock.
Insider Activity
In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company's stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business's stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company's stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.
Cigna Group Price Performance
CI opened at $299.81 on Friday. The stock has a 50-day moving average price of $297.27 and a 200-day moving average price of $308.13. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market cap of $80.03 billion, a PE ratio of 16.37, a P/E/G ratio of 0.88 and a beta of 0.45. Cigna Group has a 1 year low of $256.89 and a 1 year high of $353.55.
Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group's quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group's payout ratio is currently 32.97%.
Analyst Ratings Changes
CI has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a "buy" rating in a research report on Tuesday, August 5th. The Goldman Sachs Group initiated coverage on Cigna Group in a research report on Tuesday. They set a "buy" rating and a $370.00 price objective for the company. Wells Fargo & Company raised their price objective on Cigna Group from $340.00 to $354.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 7th. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Cigna Group in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Cigna Group has an average rating of "Moderate Buy" and an average target price of $369.89.
Check Out Our Latest Analysis on CI
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.